Cargando…

Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma

Esophageal adenocarcinoma (EAC) is a disease with dismal treatment outcomes. Response to neoadjuvant chemoradiation (CRT) varies greatly. Although the underlying mechanisms of CRT resistance are not identified, accumulating evidence indicates an important role for local antitumor immunity. To explor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goedegebuure, R.S.A., Harrasser, M., de Klerk, L.K., van Schooten, T.S., van Grieken, N.C.T., Eken, M., Grifhorst, M.S., Pocorni, N., Jordanova, E.S., van Berge Henegouwen, M.I., Pouw, R.E., Verheul, H.M.W., van der Vliet, J.J., van Laarhoven, H.W.M., Thijssen, V.L.J.L, Bass, A.J., De Gruijl, T.D., Derks, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344794/ https://www.ncbi.nlm.nih.gov/pubmed/34377591 http://dx.doi.org/10.1080/2162402X.2021.1954807

Ejemplares similares

Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies
por: de Klerk, Leonie K., et al.
Publicado: (2021)

Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer?
por: Goedegebuure, Ruben S. A., et al.
Publicado: (2019)

Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation
por: Goedegebuure, Ruben S. A., et al.
Publicado: (2021)

Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition
por: van den Ende, Tom, et al.
Publicado: (2023)

A Phase I Open‐Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26–104/RFASE in Patients with Advanced Solid Malignancies
por: Goedegebuure, Ruben S.A., et al.
Publicado: (2020)

Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma
por: Huijts, Charlotte M., et al.
Publicado: (2018)

Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer
por: Veluchamy, John Pradeep, et al.
Publicado: (2016)

Immune Cell Infiltrate in Chronic-Active Antibody-Mediated Rejection
por: Sablik, Kasia A., et al.
Publicado: (2020)

Specific tumor targeting and activation of Vγ9Vδ2 T cells by bi-specific nanobodies
por: Stam, Anita, et al.
Publicado: (2014)

High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status
por: Veluchamy, John P., et al.
Publicado: (2016)

PD-1 The impact of COVID-19 on diagnosis, stage and treatment of esophageal and gastric cancer
por: Bakx, J., et al.
Publicado: (2022)

Results of a two-phased clinical study evaluating a new multiband mucosectomy device for early Barrett’s neoplasia: a randomized pre-esophagectomy trial and a pilot therapeutic pilot study
por: Belghazi, K., et al.
Publicado: (2018)

Efficacy of PD-1 blockade in cervical cancer is related to a CD8(+)FoxP3(+)CD25(+) T-cell subset with operational effector functions despite high immune checkpoint levels
por: Heeren, A. M., et al.
Publicado: (2019)

Vacuum-stent: A combination of endoscopic vacuum therapy and an intraluminal stent for treatment of esophageal transmural defects
por: Pattynama, Lisanne M. D., et al.
Publicado: (2023)

Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs
por: Overbeek, J.K., et al.
Publicado: (2023)

Galectins in Esophageal Cancer: Current Knowledge and Future Perspectives
por: Godefa, Tesfay M., et al.
Publicado: (2022)

Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma
por: Petrillo, A., et al.
Publicado: (2022)

Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: a case series and review of literature
por: van Berge Henegouwen, J. M., et al.
Publicado: (2022)

Immunological effects of everolimus in patients with metastatic renal cell cancer
por: Huijts, Charlotte M, et al.
Publicado: (2017)

A validated HPLC-MS/MS method for simultaneously analyzing curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetra-hydrocurcumin and piperine in human plasma, urine or feces
por: Kroon, M.A.G.M., et al.
Publicado: (2023)

Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer
por: Huijts, Charlotte M, et al.
Publicado: (2011)

The relationship between stigmatisation and quality of life in Ghanaian women and men with fertility problems: mediating role of coping strategies
por: Van Rooij, FB, et al.
Publicado: (2021)

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
por: Veluchamy, John P., et al.
Publicado: (2017)

Improved efficacy of mitoxantrone in patients with castration-resistant prostate cancer after vaccination with GM-CSF-transduced allogeneic prostate cancer cells
por: van Dodewaard-de Jong, Joyce M., et al.
Publicado: (2015)

Tumor‐immune landscape patterns before and after chemoradiation in resectable esophageal adenocarcinomas
por: Soeratram, Tanya TD, et al.
Publicado: (2021)

Endoscopic vacuum therapy for anastomotic leakage after upper gastrointestinal surgery
por: Pattynama, Lisanne M. D., et al.
Publicado: (2023)

Single Domain Antibodies as Carriers for Intracellular Drug Delivery: A Proof of Principle Study
por: Pronk, Sebas D., et al.
Publicado: (2021)

The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial
por: Huijts, Charlotte M., et al.
Publicado: (2019)

Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses
por: Santegoets, S. J., et al.
Publicado: (2019)

MiR expression profiles of paired primary colorectal cancer and metastases by next-generation sequencing
por: Neerincx, M, et al.
Publicado: (2015)

The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future
por: Hamming, Lisanne C., et al.
Publicado: (2017)

[(89)Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
por: van Helden, E. J., et al.
Publicado: (2019)

Time to reimbursement of novel anticancer drugs in Europe: a case study of seven European countries
por: Post, H.C., et al.
Publicado: (2023)

HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth
por: van Schooten, Jelle, et al.
Publicado: (2018)

Stem cell mutations, associated cancer risk, and consequences for regenerative medicine
por: Derks, Lucca L.M., et al.
Publicado: (2023)

Long-term fear of cancer recurrence in patients treated endoscopically for early Barrett’s neoplasia
por: Rosmolen, Wilda D, et al.
Publicado: (2022)

Functional MRI techniques demonstrate early vascular changes in renal cell cancer patients treated with sunitinib: a pilot study
por: Desar, I.M.E., et al.
Publicado: (2011)

Effects of physical exercise on natural killer cell activity during (neo)adjuvant chemotherapy: A randomized pilot study
por: Toffoli, Elisa C., et al.
Publicado: (2021)

Functional characterization of a STAT3-dependent dendritic cell-derived CD14(+) cell population arising upon IL-10-driven maturation
por: Lindenberg, Jelle J., et al.
Publicado: (2013)

Intrathoracic versus cervical anastomosis and predictors of anastomotic leakage after oesophagectomy for cancer
por: Gooszen, J. A. H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uspn5rd53krdnl71fgu2nf5mrd